Dose effect of bilateral transcranial magnetic stimulation for depression and anxiety in a real-world clinical setting
Noah Marchuck, Raneeka DeMoss, William C. Turner, Michelle Tobar, Ben W. Hunter, Alex O. Rothbaum, Sanne J.H. van Rooij · 2026
Read Dose effect of bilateral transcranial magnetic stimulation for depression and anxiety in a real-world clinical setting by Noah Marchuck, Raneeka DeMoss, William C. Turner, Michelle Tobar, Ben W. Hunter, Alex O. Rothbaum, Sanne J.H. van Rooij (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13636056.txt.
Description
Magnetic stimulation of the brain can lift depression that drugs fail to move, and many such patients also live with anxiety. Noah Marchuck and six co-authors studied seventy-eight patients at a nonprofit clinic in 2026, comparing a standard dose with a higher dose of the treatment. Both sides of the front brain were treated.
Symptoms of both depression and anxiety fell across the course of care. About three quarters of patients responded on depression, and about half reached remission. The higher dose eased depression faster, though both groups ended at the same place. Anxiety gains did not depend on dose. The authors note the faster path could cut the number of clinic visits.
Catalog record
| CREATOR | Noah Marchuck, Raneeka DeMoss, William C. Turner, Michelle Tobar, Ben W. Hunter, Alex O. Rothbaum, Sanne J.H. van Rooij |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |